Table 2 Comorbidities and association with HbA1c
From: Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care
Mean ± SD or n (%) | Association with HbA1c1) | ||
|---|---|---|---|
Coefficient | P-value | ||
Number of comorbidities | 2.66 ± 1.6 | -0.041 | 0.459 a) |
≥1 comorbidity (n, %) | 304 (93.3) | 0.297 b) | |
0 comorbidities (n, %) | 22 (6.7) | ||
1 comorbidity (n, %) | 59 (18.1) | ||
2 comorbidities (n, %) | 73 (22.4) | ||
3 comorbidities (n, %) | 86 (26.4) | ||
≥4 comorbidities (n, %) | 86 (26.4) | ||
Hypertension (n, %) | 231 (71.3) | 0.049 b), 4c) | |
Hyperlipidemia (n, %) | 208 (66.7) | 0.097 b), 4d) | |
Adipositas (n, %)2) | 173 (53.1) | 0.057 b), 4e) | |
Obese class I (30 – 34.9) (n, %) | 111 (34.1) | ||
Obese class II (35 – 39.9) (n, %) | 42 (12.9) | ||
Obese class III (≥ 40) (n, %) | 20 (6.1) | ||
Coronary heart disease (n, %) | 66 (20.4) | 0.350 b) | |
Depression (n, %) | 38 (11.7) | 0.855 b) | |
Asthma / COPD (n, %) | 32 (9.8) | 0.460 b) | |
Myocardial infarction (n, %)3) | 30 (9.3) | 0.530 b) | |
Heart failure (n, %) | 22 (6.8) | 0.823 b) | |
Stroke (n, %)3) | 17 (5.2) | 0.747 b) | |
Cancer (n, %)3) | 13 (4.2) | 0.570 b) | |